Mutation testing is a fault-based software validation technique that involves introducing small, systematic changes (or “mutants”) into programme code to assess the capability of test suites in ...
Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. Potential NSCLC patients usually undergo invasive ...
New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in cancer and identified cancer-driving mutations in an underexplored part of ...
KIT-exon-11 mutations in GISTs correlate with higher partial response rates and improved surgical outcomes with neoadjuvant Gleevec. Non-KIT exon 11 mutations and wild-type KIT/PDGFRA GISTs show less ...
New Cleveland Clinic research reveals that up to 5% of Americans – approximately 17 million people – carry genetic mutations or "variants" linked to increased cancer susceptibility, regardless of risk ...
Research from the Ontario Institute for Cancer Research associated a chemotherapy-related cellular process with genetic mutations and used it to identify novel cancer driver alterations. Ontario ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback